HIF1A is a negative regulator of erastin- or RSL3-induced ferroptosis in human fibrosarcoma HT1080 and non-small cell lung cancer Calu-1 cells, and this anti-ferroptosis effect is linked to the activation of clockophagy, a type of selective autophagy for the degradation of the core circadian clock protein, ARNTL [55,56]. Here, BMAL1 is linked to non-small cell lung carcinoma.